USP7 is overexpressed in CLL compared with normal donors and its inhibition induces cytotoxicity in CLL cells both in vitro and in vivo, impairing homologous recombination DNA repair through the E3 ligase RAD18 destabilization. Here, USP7 is linked to B-cell chronic lymphocytic leukemia.